VAmericium-241 is a significant radiation hazard at facilities that handle or reprocess spent nuclear fuels. An inhalation intake model for 241 Am was developed using autopsy data obtained from former workers at the Radiochemical and Plutonium Production Plants at the Mayak Production Association (Mayak PA), Ozyorsk, Russia. Accumulation of 241 Am in the body can occur though direct exposure to 241 Am (termed here ''exogenous'' exposures), usually as an inhaled aerosol, or though exposure to 241 Pu that decays inside the body to 241 Am (termed here ''endogenous'' exposures). Metabolism of endogenous and exogenous 241 Am can differ, with endogenous 241 Am being initially related to the behavior of 241 Pu. For the model, it was assumed that intakes of 241 Am and 241 Pu were functionally associated with intakes of 239 Pu. The current Mayak Worker Dosimetry System model (MWDS-2008) was used to describe metabolism of plutonium and americium in the respiratory tract. The ICRP-30 model was used for the gastrointestinal tract, the ICRP-67 model was used for metabolism after absorption into the blood for americium, and the ''Leggett modification'' of the ICRP-67 model for plutonium was used for systemic, non-pulmonary organs. The proposed inhalation intake model for americium provides estimates for internal doses from 241 Am from both exogenous and endogenous sources. Health Phys. 105(1):21Y30; 2013